Skip to main content
Premium Trial:

Request an Annual Quote

Whatman to Acquire Schleicher & Schuell for 50.2M Euros

NEW YORK, Nov. 8 (GenomeWeb News) - Whatman announced today its proposed acquisition of Schleicher & Schuell for €50.2 million ($65 million).


According to Whatman, the acquisition, which will be financed in full by debt, gives it the opportunity to expand its presence in Europe, while achieving cost and revenue synergies as early as next year.


The announcement comes about four months after Whatman terminated a licensing deal with Schleicher & Schuell as part of a patent infringement lawsuit settlement.


Whatman noted that the acquisition is still subject to approval at an extraordinary general meeting scheduled for Nov. 30.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.